QT
RPTX

Quantbot Technologies’s Repare Therapeutics RPTX Stock Holding History

Quantbot Technologies’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,045
Closed -$9.63K – 1845
2024
Q1 		$9.63K Sell
2,045
-3,300
-62% -$21.1K ﹤0.01% 1458
2023
Q4 		$39K Buy
+5,345
New +$29.9K ﹤0.01% 1366
2022
Q3 		– Sell
-800
Closed -$11K – 2024
2022
Q2 		$11K Buy
+800
New +$9.42K ﹤0.01% 1521
2022
Q1 		– Sell
-2,000
Closed -$42K – 1994
2021
Q4 		$42K Buy
+2,000
New +$47.1K ﹤0.01% 1072

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Quantbot Technologies's RPTX Position: Q2 2024 in Review

Quantbot Technologies sold out of Repare Therapeutics (RPTX) in Q2 2024, closing a stake of 2,045 shares — an estimated $9.63K sold.

Quantbot Technologies first reported a position in RPTX in Q4 2021 and held it in 4 quarters. The position peaked at $42K in Q4 2021. 61 funds tracked by Wall St. Rank hold RPTX as of Q2 2024.

  • Quantbot Technologies reported no remaining Repare Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 2,045 Repare Therapeutics shares in Q2 2024, an estimated $9.63K.
  • Quantbot Technologies first reported a position in Repare Therapeutics in Q4 2021 and held it in 4 quarters.
  • Quantbot Technologies's Repare Therapeutics position peaked at $42K in Q4 2021.
  • 61 funds tracked by Wall St. Rank held Repare Therapeutics as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.